Table 4 Relative risk of maternal and fetal adverse outcome among women with SIPI and NIPI
Variable | Relative risk | 95% CI | p- value |
|---|---|---|---|
Maternal adverse Outcome | |||
PROM | 13.6 | 7.2 – 25.64 | <0.01 |
Anemia status | 3.4 | 2.8 – 4.1 | ˝ |
Pre-eclampsia | 6.75 | 3.14 –14.49 | ˝ |
PPH | 5.8 | 2.9 – 11.58 | ˝ |
Failure of trial of VBAC | 14.67 | 6.39 – 33.64 | ˝ |
Fetal adverse Outcome | |||
Pre-maturity | 9.78 | 4.9 – 19.5 | <0.01 |
Low score | 6.9 | 3.6 – 13.1 | ˝ |
LBW | 6.7 | 3.6 – 12.3 | ˝ |
SGA | 7.7 | 3.8 – 15.74 | ˝ |